News Daily News Intracoronary Abciximab Shows Advantage in Diabetic STEMI Patients L.A. McKeown August 11, 2016
News Daily News Another Meta-Analysis Supports Prolonged Bivalirudin Use in STEMI, but Is Contemporary PCI Reflected? Yael L. Maxwell July 27, 2016
News Daily News Underuse of Medical Therapy Linked With Increased Adverse Events in Very Elderly Michael O'Riordan July 21, 2016
News Daily News Antiplatelet Therapy in Stented Patients Needing Surgery: Italian Experience Provides Direction Michael O'Riordan July 20, 2016
News Daily News The EU Versus US Lipid Guideline Debate: It’s the Gap That Matters, Experts Say Shelley Wood July 19, 2016
News Daily News AstraZeneca Strives to Block Generic Crestor as Observers Call Foul Michael O'Riordan July 13, 2016
News Daily News Time for Niacin to Be ‘Relegated to Medical History’ as HPS2-THRIVE Analysis Confirms Drug’s Failings Michael O'Riordan July 12, 2016
News Daily News Statins Lower but Don’t Erase the Excess Risk of Coronary Disease and Death in Familial Hypercholesterolemia Todd Neale July 12, 2016
News Daily News Las Estatinas Minimizan pero No Eliminan el Exceso de Riesgo de Enfermedad Coronaria y Muerte en la Hipercolesterolemia Familiar Todd Neale July 12, 2016
News Daily News Media Scrutiny Over Risks and Benefits of Statins Impacts Patient Use Michael O'Riordan June 28, 2016
News Daily News Aspirin App Pairs Clinical Studies With Technology to Balance Bleeding, Benefits Michael H. Wilson June 27, 2016
News Daily News Un Nuevo Análisis Cuestiona el Mantra ‘Mejor Menos’, aunque los Expertos Piden Cautela Todd Neale June 22, 2016
News Daily News ‘Lower Is Better’ Mantra for LDL Cholesterol Questioned by New Analysis, but Experts Urge Caution Todd Neale June 22, 2016
News Daily News Prolonged Full-Dose Bivalirudin May Preserve Bleeding Benefit Without Upping Thrombotic Events After STEMI, Meta-Analysis Suggests Yael L. Maxwell June 20, 2016
News Daily News Adverse Events Linked with Statins Get a Second Look From Cholesterol Treatment Trialists’ Collaboration Michael O'Riordan June 13, 2016